- 全部删除
 
您的购物车当前为空
BAY-850 是一种具有选择性和有效的三磷酸腺苷酶家族蛋白 2 (ATAD2) 抑制剂,(IC50 : 166 nM) ,在体外和体内模型中抑制卵巢癌的生长和转移。

BAY-850 是一种具有选择性和有效的三磷酸腺苷酶家族蛋白 2 (ATAD2) 抑制剂,(IC50 : 166 nM) ,在体外和体内模型中抑制卵巢癌的生长和转移。
| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 1 mg | ¥ 1,160  | In stock | |
| 5 mg | ¥ 2,570  | In stock | |
| 10 mg | ¥ 3,830  | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 2,820  | In stock | 
BAY-850 相关产品
| 产品描述 | BAY-850 is a selective and potent inhibitor of adenosine triphosphatase family protein 2 (ATAD2) (IC50: 166 nM) that inhibits ovarian cancer growth and metastasis in in vitro and in vivo models.  | 
| 靶点活性 |  ATAD2:166 nM, tetra-acetylated peptide:115 nM (Kd), tetra-acetylated peptide:157 nM  | 
| 体外活性 | 在TR-FRET检测中,BAY-850与mono-acetylated Histone H4 N-terminal peptide竞争结合至ATAD2 BD,显示出166 nM的IC50。BAY-850以157 nM的IC50和115 nM的KD分别置换tetra-acetylated peptide。BAY-850前所未有的亚型选择性表明其作用模式与传统的BD抑制剂[1]有所不同。  | 
| 分子量 | 654.24 | 
| 分子式 | C38H44ClN5O3 | 
| CAS No. | 2099142-76-2 | 
| Smiles | COc1cc(Cl)c(cc1-c1ccc(CN[C@H](C)c2ccc(C)cc2)o1)C(=O)N[C@@H](CN[C@@H]1CC[C@H](N)CC1)Cc1ccc(cc1)C#N | 
| 密度 | 1.24 g/cm3 (Predicted) | 
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| 溶解度信息 | H2O: <0.1 mg/mL (Insoluble)  DMSO: 50 mg/mL (76.42 mM), Sonication is recommended.   | ||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5 mg/mL (7.64 mM), Sonication is recommended.  请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | ||||||||||||||||||||||||||||||
溶液配制表  | |||||||||||||||||||||||||||||||
DMSO 
  | |||||||||||||||||||||||||||||||
评论内容